Perioperative Implications of Antiretroviral Therapy: A Focus on Drug Interactions and Systemic Effects
- PMID: 40471845
- DOI: 10.1213/ANE.0000000000007613
Perioperative Implications of Antiretroviral Therapy: A Focus on Drug Interactions and Systemic Effects
Conflict of interest statement
Conflicts of Interest, Funding: Please see DISCLOSURES at the end of this article.
References
-
- Bedimo RJ, Jodlowski T. PrEParing for the end of the HIV epidemic—A public health imperative. JAMA Netw Open. 2023;6:e2330195–e2330195.
-
- Duwal S, Schütte C, von Kleist M. Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection. PLoS One. 2012;7:e40382.
-
- Landovitz RJ, Donnell D, Clement ME, et al.; HPTN 083 Study Team. Cabotegravir for HIV prevention in cisgender men and transgender women. N Engl J Med. 2021;385:595–608.
-
- Saberi P, Scott HM. On-demand oral pre-exposure prophylaxis with tenofovir/emtricitabine: What every clinician needs to know. J Gen Intern Med. 2020;35:1285–1288.
-
- Liu J, Shah SK, Basu-Ray I, Garcia-Diaz J, Khalid K, Saeed M. QT prolongation in HIV-positive patients: Review article. Indian Heart J. 2019;71:434–439.
LinkOut - more resources
Full Text Sources